NINDS tPA trial -secondary analysis based on 2 hour change in NIHSS
dc.contributor.author | Meurer, William | |
dc.date.accessioned | 2015-01-21T15:32:02Z | |
dc.date.available | 2015-01-21T15:32:02Z | |
dc.date.issued | 2015-01-21 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/110239 | |
dc.description | This was my Final Examination Project Biostatistics 581 Winter 2009, University of Michigan School of Public Health | en_US |
dc.description.abstract | The NINDS tPA stroke study was published in 1995. This medication remains the only FDA approved medication for the treatment of acute stroke. The use of this drug has remained controversial despite proven benefit; as outcomes (with respect to level of disability) were improved at 90 days. Benefit (in terms of improvement based on neurological exam) was not established in the short term as the primary outcome of part I of the study was a 4 point or more improvement in the National Institutes of Health Stroke Scale (NIHSS) at 24 hours. As there is significant biological plausibility that improvement at 24 hours is predictive of ultimate outcome it would be useful to develop a model that could predict with confidence the final degree of improvement based on changes within the first 24 hours; as this might allow for future acute stroke trials to be expedited. The Dataset: A completely de-identified data set is available from the federal government with the data from all 624 patients enrolled in the trial. Of interest for this evaluation is the serial measurements of the NIHSS score (measured at baseline or prior to treatment, 2 hours, 24 hours and 90 days.) Data on level of disability at 90 days is also described using the modified Rankin Scale (mRS), which ranges from 0 (normal), 1 (no significant disability), 2 (some disability) to 6 (death). Results:Visually comparing the trend lines suggests that the majority of the separation between the tPA and control groups is occurring when comparing baseline to two hours. This makes biological sense as well; since re-canalization of an occluded artery would be likely to lead to such observed rapid improvement. Conclusions: Change in NIHSS at 2 hours is a potential useful tool in the design of future stroke trials. | en_US |
dc.language.iso | en_US | en_US |
dc.subject | tPA, stroke, thrombolysis, outcomes | en_US |
dc.title | NINDS tPA trial -secondary analysis based on 2 hour change in NIHSS | en_US |
dc.type | Working Paper | en_US |
dc.subject.hlbsecondlevel | Emergency Medicine | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.contributor.affiliationum | Emergency Medicine, Department of | en_US |
dc.contributor.affiliationum | Neurology, Department of | en_US |
dc.contributor.affiliationum | Stroke Program | en_US |
dc.contributor.affiliationum | Michigan Center for Integrative Research on Critical Care | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/110239/1/longitudinalNINDSstudy-Meurer.pdf | |
dc.description.mapping | 118 | en_US |
dc.identifier.orcid | 0000-0002-1158-5302 | en_US |
dc.description.filedescription | Description of longitudinalNINDSstudy-Meurer.pdf : Manuscript, methods, figures and SAS code | |
dc.identifier.name-orcid | Meurer, William; 0000-0002-1158-5302 | en_US |
dc.owningcollname | Emergency Medicine |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.